References
- In that study, women were given oral zidovudine (AZT) five times daily starting in the second trimester of pregnancy through to delivery, and intravenous AZT during labour; AZT syrup was then given to the baby for six weeks. The study showed a two-thirds reduction in transmission rates, and the regimen has become the accepted standard of care in many developed countries. Connor EM, Sperling RS, Geiger R et al, 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. NEJM. 331: 1173–1180.
- P. Lurie, S.M. Wolfe. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. NEJM. 337: 1997; 853–856.
- M. Angell. The ethics of clinical research in the third world. NEJM. 337: 1997; 847–849.
- Two resign after Journal’s AIDS story. 1997; Associated Press.
- H. Varmus, D. Satcher. Ethical complexities of conducting research in developing countries. NEJM. 337(14): 1997; 1003–1005.
- J.H. Jones. Bad Blood: The Tuskegee Syphilis Experiment. 1981; Free Press: New York.